Evidence map›Paper›PMID 26172440›Full record

ArticlePloS one2015

Analysis of Toxic Amyloid Fibril Interactions at Natively Derived Membranes by Ellipsometry.

Rachel A S Smith, Aleksey Nabok, Ben J F Blakeman, Wei-Feng Xue, Benjamin Abell, David P Smith

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rachel A S SmithBiomedical Research Centre, Sheffield Hallam University, Sheffield, United Kingdom.
Aleksey NabokMaterials and Engineering Research Institute, Sheffield Hallam University, Sheffield, United Kingdom.
Ben J F BlakemanSchool of Biosciences, University of Kent, Canterbury, Kent, United Kingdom.
Wei-Feng XueSchool of Biosciences, University of Kent, Canterbury, Kent, United Kingdom.
Benjamin AbellBiomedical Research Centre, Sheffield Hallam University, Sheffield, United Kingdom.
David P SmithBiomedical Research Centre, Sheffield Hallam University, Sheffield, United Kingdom.
Sheffield Hallam University · GBUniversity of Kent · GB

Funding

Biotechnology and Biological Sciences Research Council BB/J008001/1
6 · The paper itself

Abstract

There is an ongoing debate regarding the culprits of cytotoxicity associated with amyloid disorders. Although small pre-fibrillar amyloid oligomers have been implicated as the primary toxic species, the fibrillar amyloid material itself can also induce cytotoxicity. To investigate membrane disruption and cytotoxic effects associated with intact and fragmented fibrils, the novel in situ spectroscopic technique of Total Internal Reflection Ellipsometry (TIRE) was used. Fibril lipid interactions were monitored using natively derived whole cell membranes as a model of the in vivo environment. We show that fragmented fibrils have an increased ability to disrupt these natively derived membranes by causing a loss of material from the deposited surface when compared with unfragmented fibrils. This effect was corroborated by observations of membrane disruption in live cells, and by dye release assay using synthetic liposomes. Through these studies we demonstrate the use of TIRE for the analysis of protein-lipid interactions on natively derived lipid surfaces, and provide an explanation on how amyloid fibrils can cause a toxic gain of function, while entangled amyloid plaques exert minimal biological activity.

Indexed as

Optical Phenomenaalpha-SynucleinAmyloidAmyloid beta-PeptidesAnimalsCell Line, TumorCell MembraneHumansLiposomesMuramidasePeptide FragmentsProtein Bindingalpha-SynucleinAmyloidAmyloid beta-Peptidesamyloid beta-protein (1-40)LiposomesMuramidasePeptide Fragments

Identifiers

PMID26172440
PMCPMC4501548
OpenAlexW1815329409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.